scholarly journals Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor

2016 ◽  
Vol 213 (10) ◽  
pp. 1937-1950 ◽  
Author(s):  
Eng M. Tan ◽  
Josef S. Smolen

When studies on rheumatoid arthritis (RA) that were made many decades ago and could be considered “historical” in nature are analyzed in the context of recent observations, important insights on RA and on the function of rheumatoid factor (RF) become apparent. RF in the role of antibody to immune complexes (ICs) appears to be involved in activation of the complement system and in the production of chemotactic and inflammatory mediators, creating a condition that can be sustained and reinitiated. In the synovial cavity, a state of nonresolving inflammation is produced with the formation of citrullinated protein antigen–antibody complexes or other forms of ICs. This is followed by a second wave of IC production in the form of RF acting as antibody reactive with the initial ICs. Both of these processes are associated with complement consumption and production of inflammatory mediators. We present a model of an initiation phase of RA that might represent an example of repetitive formation of ICs and complement-mediated inflammation. Targeting therapy at this phase of RA to break the cycles of recurrent inflammation might be a novel approach to aid in further control of the disease.

1991 ◽  
Vol 34 (4) ◽  
pp. 423-431 ◽  
Author(s):  
Christian Hendrich ◽  
Jens G. Kuipers ◽  
Waldemar Kolanus ◽  
Reinhold E. Schmidt ◽  
Michael Hammer

1977 ◽  
Vol 5 (1) ◽  
pp. 31-33
Author(s):  
R W Oxenhandler ◽  
E H Adelstein ◽  
W A Rogers

Ten of thirteen patients with positive histolatex agglutination titers of 1:32 or greater had no evidence of acute histoplasmosis.Three of these false positives had rheumatoid arthritis. A fourth had a rising mycoplasma complement fixation titer, and the fifth had a high titer of cold agglutinins. All of these are associated with abnormal immunoglobulin M production. To evaluate the role of rheumatoid factor in producing false positive histolatex agglutination, the histolatex test was performed on sera from 32 patients having rheumatoid factor at a titer of 1:40 or greater. Four of these sera agglutinated the histoplasmin-coated latex particles at titers of 1:32 or greater. Review of clinical records suggests the this reactivity is nonspecific. It is our purpose to call attention to rheumatoic factor as a cause of false positive histolatex agglutination.


2021 ◽  
Vol 2 (1) ◽  
pp. 19-25
Author(s):  
Wang Yu Sung ◽  
Wen Chan Tsai

Abstract Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by joint inflammation and extra-articular manifestations. Many questions in the pathogenesis, clinical manifestation, and disease spectrum are answered after the discovery of the first autoantibody namely rheumatoid factor (RF). The finding of the second autoantibody named anti-citrullinated protein antibody (ACPA), which unearths the importance of protein citrullination process. It further provides the insight how immune cells and complement interact to perpetuate the inflammatory response. These two autoantibodies pave the way for our better understanding of RA. This review article focuses on the history, pathophysiology, and clinical association of these two autoantibodies in RA.


2015 ◽  
Vol 17 (3) ◽  
pp. 367 ◽  
Author(s):  
Mihaela Cosmina Micu ◽  
Daniela Fodor

Rheumatoid arthritis (RA) is an incurable chronic inflammatory disease associated with significant functional impairment and disability, linked to inflammatory and structural articular and peri-articular damage. Structural damage occurs rapidly in RA if inflammation is not efficiently suppressed. Identification of patients with high risk to develop RA followed by an early application of efficient medications and standard ‘treat to target’ recommendations allow a better management aiming remission. Over the last 15 years musculoskeletal ultrasound (MSUS) has proved to detect subclinical inflammatory lesions; thus, targeting therapy to imaging delivered information may provide superior outcomes and a more rapid response to therapy detection in comparison with clinical examination alone. This review provides an insight into the importance of MSUS in quantifying disease activity and monitoring of therapies in RA patients.


2013 ◽  
Vol 65 (11) ◽  
pp. 2773-2782 ◽  
Author(s):  
Thomas Frisell ◽  
Marie Holmqvist ◽  
Henrik Källberg ◽  
Lars Klareskog ◽  
Lars Alfredsson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document